USP46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.550800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.387800E-01
Normal-vs-Stage2
8.616200E-01
Normal-vs-Stage3
1.974750E-01
Normal-vs-Stage4
4.883400E-01
Stage1-vs-Stage2
9.767600E-01
Stage1-vs-Stage3
1.742770E-01
Stage1-vs-Stage4
2.592800E-01
Stage2-vs-Stage3
2.312400E-01
Stage2-vs-Stage4
2.086200E-01
Stage3-vs-Stage4
5.833600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.144200E-01
Normal-vs-AfricanAmerican
5.094600E-01
Normal-vs-Asian
5.771200E-01
Caucasian-vs-AfricanAmerican
5.485500E-02
Caucasian-vs-Asian
4.925800E-01
AfricanAmerican-vs-Asian
1.048250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.414800E-01
Normal-vs-Female
9.951600E-01
Male-vs-Female
2.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.340400E-01
Normal-vs-Age(41-60Yrs)
7.326400E-01
Normal-vs-Age(61-80Yrs)
6.888000E-01
Normal-vs-Age(81-100Yrs)
3.384200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.657600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.174800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.203000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.017700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.432400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.679600E-01
Normal-vs-Daily Drinker
4.746200E-01
Normal-vs-Weekly Drinker
9.865400E-01
Normal-vs-Occasional Drinker
8.360600E-01
Normal-vs-Social Drinker
8.684000E-01
Non Drinker-vs-Daily Drinker
6.952000E-01
Non Drinker-vs-Weekly Drinker
3.610800E-01
Non Drinker-vs-Occasional Drinker
6.253600E-02
Non Drinker-vs-Social Drinker
9.630400E-02
Daily Drinker-vs-Weekly Drinker
2.486400E-01
Daily Drinker-vs-Occasional Drinker
6.940100E-02
Daily Drinker-vs-Social Drinker
1.036830E-01
Weekly Drinker-vs-Occasional Drinker
8.069400E-01
Weekly Drinker-vs-Social Drinker
8.488400E-01
Occasional Drinker-vs-Social Drinker
9.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.568600E-01
Normal-vs-Grade 2
7.842200E-01
Normal-vs-Grade 3
8.019800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.356800E-01
Grade 1-vs-Grade 3
2.744600E-01
Grade 1-vs-Grade 4
7.568600E-01
Grade 2-vs-Grade 3
5.629600E-01
Grade 2-vs-Grade 4
7.842200E-01
Grade 3-vs-Grade 4
8.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.344000E-01
Normal-vs-NonDiabetic
8.475200E-01
Diabetic-vs-NonDiabetic
3.572000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.347000E-01
Normal-vs-NoPancreatitis
7.537800E-01
Pancreatitis-vs-NoPancreatitis
9.012000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.673200E-01
Normal-vs-N1
8.632400E-01
N0-vs-N1
9.937200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.854600E-01
Normal-vs-TP53-NonMutant
8.182200E-01
TP53-Mutant-vs-TP53-NonMutant
8.337600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
